Cleared Traditional

K162287 - Synapse 3D Perfusion Analysis

K162287 is the FDA 510(k) clearance for Synapse 3D Perfusion Analysis by Fujifilm Medical Systems U.S.A, Inc.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 234-day FDA review.

K162287 · Fujifilm Medical Systems U.S.A, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2017
Decision
234d
Days
Class 2
Risk

K162287 is an FDA 510(k) clearance for the Synapse 3D Perfusion Analysis. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Fujifilm Medical Systems U.S.A, Inc. (Stamford, US). The FDA issued a Cleared decision on April 6, 2017 after a review of 234 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Fujifilm Medical Systems U.S.A, Inc. devices

Submission Details

510(k) Number K162287 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 15, 2016
Decision Date April 06, 2017
Days to Decision 234 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
127d slower than avg
Panel avg: 107d · This submission: 234d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1096
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K162287.
NuVasive NuvaLine Mobile App
K162647 · Nu Vasive, Incorporated · May 2017
syngo.CT View&GO
K170952 · Siemens Medical Solutions USA, Inc. · Apr 2017
Carestream Vue PACS
K170580 · Carestream Health, Inc. · Apr 2017
Move Forward 3D Motion Simulation Service
K162559 · Biomet, Inc. · Mar 2017
FDX Console (DR-ID300CL) Software
K170451 · Fujifilm Medical Systems U.S.A, Inc. · Mar 2017
Lung Nodule Assessment and Comparison Option (LNA)
K162484 · Philips Medical Systems Nederland B.V. · Feb 2017